Inovalon to Participate at 2018 RBC Capital Markets Global Healthcare Conference
February 15 2018 - 1:00PM
Inovalon (Nasdaq:INOV), a leading technology company providing
advanced, cloud-based platforms empowering a data-driven
transformation from volume-based to value-based models across the
healthcare ecosystem, today announced that Keith Dunleavy, M.D.,
chief executive officer and chairman of the board of Inovalon, and
Christopher Greiner, chief financial officer and chief operating
officer of Inovalon, will present at the RBC Capital Markets Global
Healthcare Conference on February 22, 2018, at the New York Palace
Hotel in New York City.
Investors may access the conference materials on
the Investor Relations section of Inovalon’s website at
www.inovalon.com.
About Inovalon
Inovalon is a leading technology company
providing cloud-based platforms empowering a data-driven
transformation from volume-based to value-based models throughout
the healthcare industry. Through the Inovalon ONE™ Platform,
Inovalon brings to the marketplace a national-scale capability to
interconnect with the healthcare ecosystem, aggregate and analyze
data in petabyte volumes to arrive at sophisticated insights in
real-time, drive impact wherever it is analytically identified best
to intervene, and intuitively visualize data and information to
inform business strategy and execution. Leveraging its platform,
unparalleled proprietary data sets, and industry-leading subject
matter expertise, Inovalon enables the assessment and improvement
of clinical and quality outcomes and financial performance across
the healthcare ecosystem. From health plans and provider
organizations, to pharmaceutical, medical device, and diagnostics
companies, Inovalon's unique achievement of value is delivered
through the effective progression of “Turning Data into Insight,
and Insight into Action®.” Providing technology that supports
nearly 500 healthcare organizations, Inovalon's platforms are
informed by data pertaining to more than 903,000 physicians, more
than 385,000 clinical facilities, and 231 million Americans. For
more information, visit www.inovalon.com.
Contacts:Kim CollinsPhone:
301-809-4000
x1473
kcollins@inovalon.com
George Price (Investors)Phone: 301-809-4000
x1190gprice@inovalon.com
Inovalon (NASDAQ:INOV)
Historical Stock Chart
From Mar 2024 to Apr 2024
Inovalon (NASDAQ:INOV)
Historical Stock Chart
From Apr 2023 to Apr 2024